Cargando…

Effects of the second dose of COVID-19 vaccines in patients with autoimmune rheumatic diseases with hybrid immunity

Patients with autoimmune rheumatic diseases with a previous infection by the SARS-CoV-2 virus have exaggerated responses to a single dose of COVID-19 vaccination as compared to fully vaccinated infection naive patients. The second dose is currently recommended at an extended gap after the infection,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Menon, Aparna R., Cherian, Somy, Paul, Aby, Kumar, Kripesh, Ahmed, Sakir, Mehta, Pankti, Musthafa, Shaik, Gayathri, B., Benny, Libin, Shenoy, Padmanabha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Observational Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801343/ https://www.ncbi.nlm.nih.gov/pubmed/36583801 http://dx.doi.org/10.1007/s00296-022-05265-3

Ejemplares similares

Effectiveness of delayed second dose of AZD1222 vaccine in patients with autoimmune rheumatic disease
por: Mehta, Pankti, et al.
Publicado: (2022)

Correlates of breakthrough Omicron (B.1.1.529) infections in a prospective cohort of vaccinated patients with rheumatic diseases
por: Benny, Libin, et al.
Publicado: (2023)

Hybrid immunity versus vaccine-induced immunity against SARS-CoV-2 in patients with autoimmune rheumatic diseases
por: Shenoy, Padmanabha, et al.
Publicado: (2022)

Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey
por: Cherian, Somy, et al.
Publicado: (2021)

Withholding methotrexate after COVID-19 vaccination: different strategies, same results? – Author's reply
por: Mehta, Pankti, et al.
Publicado: (2022)

Antibody responses after documented COVID-19 disease in patients with autoimmune rheumatic disease
por: Shenoy, Padmanabha, et al.
Publicado: (2021)

Switching to teleconsultation for rheumatology in the wake of the COVID-19 pandemic: feasibility and patient response in India
por: Shenoy, Padmanabha, et al.
Publicado: (2020)

Rituximab-associated hypogammaglobulinemia in autoimmune rheumatic diseases: a single-center retrospective cohort study
por: Wade, Stefanie D., et al.
Publicado: (2021)

COVID-19 vaccine hesitancy in patients with systemic autoimmune rheumatic disease: an interview-based survey
por: Gaur, Priyanka, et al.
Publicado: (2021)

Adverse events of six COVID-19 vaccines in patients with autoimmune rheumatic diseases: a cross-sectional study
por: Esquivel-Valerio, Jorge Antonio, et al.
Publicado: (2021)

Withholding methotrexate after vaccination with ChAdOx1 nCov19 in patients with rheumatoid or psoriatic arthritis in India (MIVAC I and II): results of two, parallel, assessor-masked, randomised controlled trials
por: Skaria, Teny Grace, et al.
Publicado: (2022)

Increased influenza vaccination rates in patients with autoimmune rheumatic diseases during the Covid-19 pandemic: a cross-sectional study
por: Fragoulis, George E., et al.
Publicado: (2021)

Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience
por: Migkos, Michalis P., et al.
Publicado: (2021)

Clinical characteristics and outcome of COVID-19 in patients with rheumatic diseases
por: Alzahrani, Zeyad A., et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on the frequency of the pediatric rheumatic diseases
por: Kaya Akca, Ummusen, et al.
Publicado: (2021)

Impact of COVID-19 pandemic on patients with rheumatic diseases in Latin America
por: Fernández-Ávila, Daniel G., et al.
Publicado: (2021)

YouTube as a source of information on COVID-19 vaccination in rheumatic diseases
por: Kocyigit, Burhan Fatih, et al.
Publicado: (2021)

Psychosocial and clinical effects of the COVID-19 pandemic in patients with childhood rheumatic diseases and their parents
por: Durcan, Gizem, et al.
Publicado: (2021)

Middle East Respiratory Syndrome Coronavirus Antibodies in Bactrian and Hybrid Camels from Dubai
por: Lau, Susanna K. P., et al.
Publicado: (2020)

The COVID-19 epidemic curve and vaccine acceptance among patients with rheumatic diseases: an ecological study
por: Gastelum-Strozzi, Alfonso, et al.
Publicado: (2023)

The impact of the ongoing COVID-19 pandemic on the management of rheumatic disease: a national clinician-based survey
por: Kahveci, Abdulvahap, et al.
Publicado: (2022)

Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews
por: Karaarslan, Fatih, et al.
Publicado: (2021)

Telemedicine for patients with rheumatic and musculoskeletal diseases during the COVID-19 pandemic; a positive experience in the Netherlands
por: Bos, Wouter H., et al.
Publicado: (2021)

Observations on the Medicinal Uses of the Oleum Fecoris Aselli, or Cod Liver Oil, in the Chronic Rheumatism, and Other Painful Disorders
Publicado: (1782)

How to optimize recruitment strategies of patients with rheumatic and musculoskeletal diseases for online surveys: experience from an international study
por: Hmamouchi, Ihsane, et al.
Publicado: (2022)

Genetics and Autoimmunity: Two Sides of the Same Coin or an Epiphenomenon?
por: Chatterjee, Rudrarpan, et al.
Publicado: (2022)

Autoimmune Rheumatic Diseases
por: Anaya, Juan-Manuel, et al.
Publicado: (2014)

Characterization of a Conjugative Hybrid Plasmid Coharboring bla(KPC-2) and bla(IMP-4) in a Klebsiella quasipneumoniae Clinical Isolate
por: Dong, Huiyue, et al.
Publicado: (2023)

Type 1 diabetes and associated autoimmune diseases
por: Frommer, Lara, et al.
Publicado: (2020)

Public interest in rheumatic diseases and rheumatologist in the United States during the COVID-19 pandemic: evidence from Google Trends
por: Kardeş, Sinan, et al.
Publicado: (2020)

Isolation in patients with inflammatory rheumatic diseases during COVID-19 pandemic compared to healthy individuals: a questionnaire survey
por: Eriksen, Tobias Eschricht, et al.
Publicado: (2022)

The prevalence of foot health problems in people living with a rheumatic condition: a cross-sectional observational epidemiological study
por: Stolt, Minna, et al.
Publicado: (2022)

Does immunosuppressive treatment entail an additional risk for children with rheumatic diseases? A survey-based study in the era of COVID-19
por: Koker, Oya, et al.
Publicado: (2020)

COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study
por: Fragoulis, George E., et al.
Publicado: (2021)

Patients with rheumatic diseases are ready to use social media in clinical practice; what about rheumatologists? A cross-sectional survey
por: Erdogan, M., et al.
Publicado: (2021)

Management of chronic rheumatic diseases in women 18–45 years of age in Asia Pacific: insights from patient and clinician surveys
por: Tanaka, Yoshiya, et al.
Publicado: (2022)

A survey of Canadian adult rheumatologists’ knowledge, comfort level, and barriers in assessing psychosocial needs of young adults with rheumatic diseases
por: Prasad, Madhavi, et al.
Publicado: (2023)

A prospective longitudinal study evaluating the influence of immunosuppressives and other factors on COVID-19 in autoimmune rheumatic diseases
por: Patil, Abhishek, et al.
Publicado: (2022)

Adult intussusception: A case series and review
por: Shenoy, Santosh
Publicado: (2017)

Association of stiff-person syndrome with autoimmune endocrine diseases
por: Lee, Yi-Yin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ibksto50jv6ve775lmmn5ljpel